Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings

There is a clear requirement for an accurate SARS-CoV-2 antibody test, both as a complement to existing diagnostic capabilities and for determining community seroprevalence. We therefore evaluated the performance of a variety of antibody testing technologies and their potential use as diagnostic too...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PLoS pathogens 2020-09, Vol.16 (9), p.e1008817-e1008817
Hauptverfasser: Pickering, Suzanne, Betancor, Gilberto, Galão, Rui Pedro, Merrick, Blair, Signell, Adrian W, Wilson, Harry D, Kia Ik, Mark Tan, Seow, Jeffrey, Graham, Carl, Acors, Sam, Kouphou, Neophytos, Steel, Kathryn J A, Hemmings, Oliver, Patel, Amita, Nebbia, Gaia, Douthwaite, Sam, O'Connell, Lorcan, Luptak, Jakub, McCoy, Laura E, Brouwer, Philip, van Gils, Marit J, Sanders, Rogier W, Martinez Nunez, Rocio, Bisnauthsing, Karen, O'Hara, Geraldine, MacMahon, Eithne, Batra, Rahul, Malim, Michael H, Neil, Stuart J D, Doores, Katie J, Edgeworth, Jonathan D
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!